Terms: = Bone cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP AND Treatment
4 results:
1. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis of the 19th ArgoSpine Symposium.
Kehr P; Graftiaux A; Richard N; Mazel C
Eur J Orthop Surg Traumatol; 2015 Jul; 25 Suppl 1():S253-64. PubMed ID: 25993977
[TBL] [Abstract] [Full Text] [Related]
3. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.
Kozanoglu I; Yandim MK; Cincin ZB; Ozdogu H; Cakmakoglu B; Baran Y
J Cancer Res Clin Oncol; 2013 Feb; 139(2):327-35. PubMed ID: 23080133
[TBL] [Abstract] [Full Text] [Related]
4. Oncogenic activation of NF-kappaB.
Staudt LM
Cold Spring Harb Perspect Biol; 2010 Jun; 2(6):a000109. PubMed ID: 20516126
[TBL] [Abstract] [Full Text] [Related]
